Experimental ‘Off-the-Shelf’ Cancer Vaccine Is Already Prolonging Lives, Study Suggests
An experimental “off-the-shelf” vaccine for recurring pancreatic and colorectal cancer is showing great promise so far. Early results show that the vaccine appears to be safe and is potentially prolonging people’s lives. Researchers at the University of California, Los Angeles, the Memorial Sloan Kettering Cancer Center in New York, and elsewhere are developing the vaccine, called ELI-002. In Phase I trial data released this week, people who received ELI-002 often developed an immune response t